Seven percent hypertonic saline - 0.1% hyaluronic acid in infants with mild-to-moderate bronchiolitis

Pediatric Pulmonology

Volumn 49, Issue 9, 2014, Pages 919-925

  Nenna, Raffaella ^a   Papoff, Paola ^a   Moretti, Corrado ^a   De Angelis, Daniela ^a   Battaglia, Massimo ^a   Papasso, Stefano ^a   Bernabucci, Mariangela ^a   Cangiano, Giulia ^a   Petrarca, Laura ^a   Salvadei, Serena ^a   Nicolai, Ambra ^a   Ferrara, Marianna ^a   Bonci, Enea ^a   Midulla, Fabio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

7 hypertonic saline; bronchiolitis; hospital treatment; hyaluronic acid; therapy

Indexed keywords

CORTISONE; HYALURONIC ACID; SALBUTAMOL; SODIUM CHLORIDE; VISCOSUPPLEMENT;

ANTIBIOTIC THERAPY; ARTICLE; BRONCHIOLITIS; CHILD HOSPITALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INFANT; LENGTH OF STAY; MALE; NEBULIZER; OXYGEN THERAPY; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA;

BRONCHIOLITIS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYALURONIC ACID; INFANT; LENGTH OF STAY; MALE; MULTIVARIATE ANALYSIS; NEBULIZERS AND VAPORIZERS; PROSPECTIVE STUDIES; SALINE SOLUTION, HYPERTONIC; SEVERITY OF ILLNESS INDEX; VISCOSUPPLEMENTS;

EID: 84906316894     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.22935     Document Type: Article

References (30)

1. Smyth RL, Openshaw PJ,. Bronchiolitis. Lancet 2006; 368: 312-322.
2. Panitch HB,. Bronchiolitis in infants. Curr Opin Pediatr 2001; 13: 256-260.
3. Girard MP, Cherian T, Pervikov Y, Kieny MP,. A review of vaccine research and development: human acute respiratory infections. Vaccine 2005; 23: 5708-5724.
4. Brand PL, Vaessen-Verbene AA,. Differences in management of bronchiolitis between hospitals in the Netherlands. Dutch paediatric respiratory society. Eur J Pediatr 2000; 159: 343-347.
5. Gadomski AM, Lichenstein R, Horton L, King J, Keane V, Permutt T,. Efficacy of albuterol in the management of bronchiolitis. Pediatrics 1994; 93: 907-1012.
6. van Woensel JB, Wolfs TF, van Aalderen WM, Brand PL, Kimpen JL,. Randomized double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis. Thorax 1997; 52: 634-637.
7. Wainwright C, Altamirano L, Cheney M, Cheney J, Barber S, Price D, Moloney S, Kimberley A, Woolfield N, Cadzow S, et al. A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. New Eng J Med 2003; 349: 27-35.
8. Nenna R, Tromba V, Berardi R, De Angelis D, Papoff P, Sabbatino G, Moretti C, Midulla F,. Recombinant human deoxyribonuclease treatment in hospital management of infants with moderate-severe bronchiolitis. Eur J Inflamm 2009; 7: 169-174.
9. Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP,. Nebulized hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev 2008; 4: CD006458.
10. Mandelberg A, Tal G, Witzling M, Someck E, Houri S, Balin A, Priel IE,. Nebulized 3% hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis. Chest 2003; 123: 481-487.
11. Luo Z, Liu E, Luo J, Li S, Zeng F, Yang X, Fu Z,. Nebulized hypertonic saline/salbutamol solution treatment in hospitalized children with mild to moderate bronchiolitis. Pediatr Int 2010; 52: 199-202.
12. Tal G, Cesar K, Oron A, Houri S, Ballin A, Mandelberg A,. Hypertonic saline/epinephrine treatment in hospitalized infants with viral bronchiolitis reduces hospitalization stay: 2 years experience. Isr Med Assoc J 2006; 8: 169-173.
13. Suenaga T, Suzuki H, Shibuta S, Takeuchi T, Yoshikawa N,. Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants. J Pediatr 2007; 151: 266-270.
14. Grewal S, Ali S, McConnell DW, Vandermeer B, Klassen TP,. A randomized trial of nebulized 3% hypertonic saline with epinephrine in the treatment of acute bronchiolitis in the emergency department. Arch Pediatr Adolesc Med 2009; 163: 1007-1012.
15. Anil AB, Anil M, Saglam AB, Cetin N, Bal A, Aksu N,. High volume normal saline alone is as effective as nebulized salbutamol-normal saline, epinephrine-normal saline, and 3% saline in mild bronchiolitis. Pediatr Pulmonol 2010; 45: 41-47.
16. Al-Ansari K, Sakran M, Davidson BL, El Sayyed R, Mahjoub H, Ibrahim K,. Nebulized 5% or 3% hypertonic or 0.9% saline for treating acute bronchiolitis in infants. J Pediatr 2010; 157: 630-634.
17. Mandelberg A, Amirav I,. Hypertonic saline or high volume normal saline for viral bronchiolitis: mechanisms and rationale. Ped Pulmunol 2010; 45: 36-40.
18. Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, Belousova EG, Xuan W, Bye PT, National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006; 354: 229-240.
19. Randell SH, Boucher RC,. Effective mucus clearance is essential for respiratory health. Am J Respir Cell Mol Biol 2006; 35: 20-28.
20. Boogard R, de Jongste J, Merkus P,. Pharmacotherapy of impaired mucociliary clearance in non-CF pediatric lung disease. Pediatr Pulmonol 2007; 42: 989-1001.
21. Robinson M, Hemming AL, Regnis JA, Wong AG, Bailey DL, Bautovich GJ, King M, Bye PT,. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax 1997; 52: 900-903.
22. Ziment I,. Respiratory pharmacology and therapeutics. Philadelphia: WB Saunders; 1978.
23. Wark PA, McDonald V, Jones AP,. Nebulised hypertonic saline for cystic fibrosis. Cochrane Database Syst Rev 2005; 3: CD001506.
24. Suri R, Metcalfe C, Lees B, Grieve R, Flather M, Normand C, Thompson S, Bush A, Wallis C,. Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial. Lancet 2001; 358: 1316-1321.
25. Petrigni G, Allegra L,. Aerosolised hyaluronic acid prevents exercise-induced bronchoconstriction, suggesting novel hypotheses on the correction of matrix defects in asthma. Pulm Pharmacol Ther 2006; 19: 166-171.
26. Buonpensiero P, De Gregorio F, Sepe A, Di Pasqua A, Ferri P, Siano M, Terlizzi V, Raia V,. Hyaluronic acid improves "pleasantness" and tolerability of nebulized hypertonic saline in a cohort of patients with cystic fibrosis. Adv Ther 2010; 27: 870-878.
27. Midulla F, Scagnolari C, Bonci E, Pierangeli A, Antonelli G, De Angelis D, Berardi R, Moretti C,. Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants. Arch Dis Child 2010; 95: 35-41.
28. Midulla F, Pierangeli A, Cangiano G, Bonci E, Salvadei S, Scagnolari C, Moretti C, Antonelli G, Ferro V, Papoff P,. Rhinovirus bronchiolitis and recurrent wheezing: one year follow-up. Eur Respir J 2012; 39: 396-402.
29. Sood N, Bennett WD, Zeman K, Brown J, Foy C, Boucher RC, Knowles MR,. Increasing concentration of inhaled saline with or without amiloride: effect on mucociliary clearance in normal subjects. Am J Respir Crit Care Med 2003; 167: 158-163.
30. Cantor JO,. Potential therapeutic applications of hyaluronan in the lung. Int J COPD 2007; 2: 283-288.